Maritime dock

Other Names

American Golden DockBristle DockGolden DockGolden or Maritime DockLapathum minusLapathum minus LamarckRumex aureusRumex aureus MillerRumex maritimeRumex maritimusRumex maritimus L.Sea-side DockSeashore DockSeaside Dock

Synopsis

Maritime Dock (Rumex maritimus L.): A Comprehensive Encyclopedic Reference

1. Identity and Botanical Classification

1.1 Nomenclature and Synonyms

Maritime Dock (Rumex maritimus L.) is commonly called golden dock, bristle dock, or seashore dock, and is an annual plant species of the genus Rumex. Within the broader ethnobotanical literature it is also called sea dock. This herb belongs to the family Polygonaceae. The genus name Rumex itself has classical Latin origins: the name Rumex originated from the Latin word for dart, alluding to the shape of the leaves.

1.2 Position Within the Genus Rumex

The genus Rumex (Polygonaceae), comprising about 193 species, is widely distributed across temperate and subtropical regions of Europe, Asia, Africa, and North America, and has long been used in traditional medicine worldwide. Rumex is the second largest genus of family Polygonaceae with almost 200 species distributed in Europe, Asia, Africa and North America, mainly in the northern hemisphere. R. maritimus is listed among the 28 species of the Rumex genus that have been formally documented for use in traditional medicine.

1.3 Morphological Description

Rumex maritimus is an annual, occasionally biennial plant growing from an erect, spindle-shaped root; the erect, branched stems can grow around 15–75 cm tall. The lifespan of Rumex maritimus is rarely biennial in moist environments. Rumex maritimus is composed of golden yellow or green/yellow inflorescences on its leaves and stem. The leaves are wedge-shaped, commonly narrow on both ends, but are rarely broadly wedge-shaped, ranging from 7 cm wide and 1.5 cm in height to 25 cm wide and 4 cm in height, containing blades that are lanceolate or lanceolate-linear. The flower produces 15 to 30 triangular or rhombic triangular flowers ranging from 2.5 mm wide and 0.75 mm tall to 3 mm wide and 1.2 mm tall.

1.4 Natural Habitat and Geographic Distribution

Rumex maritimus L. (Polygonaceae) is a wetland annual herb widely distributed across Europe, Asia and North America, with significant populations in the floodplains and wetlands of Manipur, India. Rumex maritimus also grows in Argentina, Burma, Canada, China, and the United States, and is native to Canada and most of the 48 contiguous states. Rumex maritimus frequently grows in areas that flood with water. Shoots that are elongated are grown during mid summer or summer, while shoots that are not elongated reproduce during flooding season because the water transports its seeds. Ecologically, it functions as a pioneer species, colonizing moist, sandy-loamy soils along riverbanks and marshes, contributing to soil stabilization and wetland biodiversity.

Rumex maritimus is very rare in Ireland but has been recorded from County Cork from about 1870, and in Britain it is noted as local. According to the U.S. federal government, the Connecticut 'seaside dock' is of special conservation concern, and in New York 'golden dock' is considered endangered.

1.5 Plant Parts Used and Common Preparations

Most organs in Rumex maritimus are used for medical purposes. The roots, seeds, and leaves are the principal parts documented in traditional and scientific contexts. The species is traditionally used by the Meitei community of Manipur for gastrointestinal, dermatological and inflammatory conditions, with roots, seeds and leaves forming the principal medicinal components. The plant is harvested from the wild for local use as a food and medicine. In ethnobotanical documentation, preparations include decoctions and extracts of the root, topical applications of leaf material, and use of seeds in food or tonic preparations. As a dietary supplement, the dried plant material is extracted by successive methanolic extraction for pharmacological study, as described in published research; however, no standardized commercial supplement form specific to R. maritimus (as opposed to its close relative R. crispus) has been validated in clinical trials.

2. Traditional and Historical Use

2.1 South Asian Traditions

R. maritimus and R. nepalensis, used as laxatives, have long-term medicinal applications in India as substitutes for Rheum palmatum (Polygonaceae), which is usually used to regulate the whole digestive system. Indians have recorded nine Rumex plants as astringent agents, including R. maritimus.

Among communities in the floodplains and wetlands of Manipur, India, the Meitei community has traditionally used R. maritimus for gastrointestinal, dermatological and inflammatory conditions, with roots, seeds and leaves forming the principal medicinal components.

2.2 Ethnomedicinal Uses Across Cultures

R. maritimus has a number of ethnomedicinal uses; as examples, its leaves are applied against burns, while the seeds, which are tonic, are used to eliminate pain from the back and the lumbar region and as an aphrodisiac. The leaves have also been used to cure external burns and ringworm, and the roots to cure skin diseases. Seeds have been ground into powder for food use.

In Bangladesh, India, North Africa and the Americas, the leaf, root and seed of R. maritimus have been used traditionally, with leaves and roots employed as laxatives and external remedies.

2.3 The Broader Rumex Tradition Contextualizing R. maritimus

The roots of many species belonging in the Rumex genus have been used in medicine from ancient times because of their gentle laxative effect. Some Rumex species, called "sorrel" or "dock," have been used as food and in treatment of skin diseases and hemostasis after trauma by the local people of their growing areas for centuries. The aerial parts, leaves, and roots of the plants are used as vegetables and for the treatment of several health disorders such as mild diabetes, constipation, infections, diarrhoea, oedema, jaundice, and as an antihypertensive, diuretic and analgesic, and in cases of skin, liver and gallbladder disorders, and inflammation.

Present findings in ethnobotanical surveys reveal that leaves are the most frequently utilised plant parts as foods (mainly in fresh form), while leaves and roots are applied preferably for the treatment of different diseases.

3. Phytochemistry: Key Constituents and Active Compounds

3.1 Overview of the Chemical Profile

Phytochemical investigations of R. maritimus reveal the presence of anthraquinones, flavonoids, phenolic acids, tannins, saponins and minor alkaloids, which support its antioxidant, antimicrobial, antidiarrheal and hepatoprotective activities. Phytochemical analysis of the extract of R. maritimus indicates the presence of reducing sugar, glycoside, gum, tannin and alkaloid-type compounds.

These species are rich in diverse phytochemicals, including anthraquinones, flavonoids, tannins, naphthalenes, and stilbenes, which contribute to a broad range of biological activities. This profile is consistent across the genus, and specific compounds have been isolated directly from R. maritimus and closely related dock species.

3.2 Anthraquinones

Anthraquinones are considered to be important taxonomic markers of the Polygonaceae family; especially emodin, chrysophanol and physcion have been isolated from many plants. All species studied contained emodin, chrysophanol and physcion and in addition some contained aloe-emodin (with a side chain oxidized to the alcohol) and others rhein or rhein-like substances (with side chain oxidized to the acid).

An isolated compound of Rumex maritimus was specifically reported for anthraquinone, chromone and flavone derivatives, and 2-methoxystypandrone, and the root of the plant represented stronger antioxidant activity and antidiarrhoeal activity in an animal model.

Anthraquinones including anthranones and seco-anthraquinones and their glycosides and dimers have been isolated and identified from more than 17 Rumex species. Anthraquinone O- and C-glycosides, with glucose, galactose, rhamnose, and 6-hydroxyacetylated glucose as commonly existing sugar moieties, are normally found in Rumex.

3.3 Naphthalene Derivatives: 2-Methoxystypandrone

A distinctive compound isolated specifically from R. maritimus is the naphthalenedione derivative 2-methoxystypandrone. Belonging to the Polygonaceae family, Rumex maritimus is known to have a wide range of biological properties, though its phytotoxic properties are not well documented. A focused investigation was conducted into the phytotoxic potential of R. maritimus and its phytotoxic substances. Leaf, stem and root extracts of R. maritimus exhibited strong inhibitory effects on root and shoot length of Lactuca sativa, Medicago sativa, Lolium multiflorum, and Phleum pratense. One substance, 2-methoxystypandrone, was purified after a series of chromatography and characterized by spectral data.

The same compound, when isolated from related dock species, shows additional pharmacological signals: 2-methoxystypandrone, isolated from R. japonicus, displayed antiproliferative activity against Jurkat cells; this effect was associated with a reduction in mitochondrial membrane potential and an increase in mitochondrial reactive oxygen species.

3.4 Flavonoids

Besides anthraquinones, other main chemical constituents of the Rumex genus are flavonoids. The flavonoid profile indicates that the subgenus Rumex is characterized by the presence of flavonols. Within the broader genus, key flavonoids identified include quercetin-3-O-glucoside, as well as kaempferol-related compounds. Quercetin 3-O-glucoside, emodin, nepodin, torachrysone, and trans-resveratrol have been highlighted as particularly promising isolated compounds for further investigation to find novel therapeutics.

3.5 Tannins, Phenolic Acids, and Stilbenes

To date, 29 Rumex species have been studied to contain about 268 substances, including anthraquinones, flavonoids, naphthalenes, stilbenes, diterpene alkaloids, terpenes, lignans, and tannins. Tannins confer the well-documented astringent quality to many dock preparations. The genus Rumex is characterized by the accumulation of anthraquinones, naphthalene-1,8-diols, flavonoids and stilbenoids.

3.6 Oxalic Acid Content

Plants of Rumex can contain quite high levels of oxalic acid, which gives the leaves of many members of this genus an acid-lemon flavour. Perfectly acceptable in small quantities, the leaves should not be eaten in large amounts since the oxalic acid can lock up other nutrients in the food, especially calcium, thus causing mineral deficiencies.

4. Mechanisms of Action

4.1 Anthraquinone-Mediated Laxative Effect

The laxative and antidiarrhoeal effects ascribed to Rumex roots, including R. maritimus, are primarily attributed to anthraquinone glycosides. Anthraquinone aglycones, such as emodin, exert their laxative action by stimulating colonic peristalsis and reducing fluid reabsorption from the intestinal lumen. The antidiarrhoeal effect, which may appear paradoxical, is consistent with dose-dependent modulation of gastrointestinal motility, where the tannin content and other astringent constituents may reduce intestinal secretion at lower doses. Extracts of the related Rumex dentatus and its phytoconstituents have been considered potent antioxidant and anti-inflammatory candidates that possess anti-diarrheal, anti-secretory, antispasmodic, anti-H. pylori, and anti-ulcer potential.

4.2 Antioxidant Mechanisms

Pharmacological studies on Rumex extracts and pure components have revealed a wide range of bioactivities, involving antimicrobial, anti-inflammatory, antiviral, renal and gastrointestinal protective effects, antioxidant, antitumor, and anti-diabetes effects. The antioxidant mechanism in Rumex species is primarily attributed to free-radical scavenging by phenolic compounds and flavonoids. Ethyl acetate fractions of leaves and roots of R. dentatus exhibited strong DPPH radical scavenging activity, with IC50 values of 21 and 12 μg/mL, respectively.

4.3 Antimicrobial Mechanisms

A bacteriostasis experiment with two naphthalenes, torachrysone and 2-methoxystypandrone, isolated from R. japonicus roots, showed inhibitory effects on both Gram-negative and Gram-positive bacteria. Bioassay-guided isolation of R. abyssinicus yielded six antimicrobial quinones — chrysophanol and its 8-O-β-D-glucoside, emodin, 6-hydroxyemodin, physcion and its 8-O-β-D-glucoside — with MIC values of 8–256 μg/mL.

4.4 Anti-inflammatory Mechanisms

The main biologically active compounds isolated from Rumex species, including quinones, flavonoids, tannins, terpenes, alkaloids, and large quantities of anthracene derivatives, are considered responsible for anti-inflammatory and anticancer properties. Anti-inflammatory activity in the genus has been demonstrated through inhibition of protein denaturation, membrane stabilization, and modulation of pro-inflammatory mediators in preclinical models. These mechanisms, documented for the genus, are considered to apply to R. maritimus given its shared phytochemical constituents, though direct mechanistic studies specific to this species remain limited.

5. Scientific Evidence by Area of Use

5.1 Gastrointestinal Activity and Antidiarrheal Effect

The most pharmacologically studied application specific to R. maritimus is its antidiarrheal activity. The foundational study for this is:

Rouf ASS, Islam MS, Rahman MT (2003) — A pre-clinical animal study published in the Journal of Ethnopharmacology (PMID: 12648830). The dried plants were subjected to successive extraction with methanol and the extract was used to investigate the activities. The extract produced good diarrheal inhibition in castor oil-induced diarrhea in mice at 250 mg/kg and 500 mg/kg body weight, which was comparable to the standard drug Loperamide at the dose of 3 mg/kg of body weight. The alcoholic extract also showed antibacterial activity against the tested microorganisms, including both Gram-positive and Gram-negative bacteria.

Evidence strength: This evidence is preclinical only (animal model). No human clinical trials examining antidiarrheal effects of R. maritimus have been identified in the peer-reviewed literature. The animal data is preliminary and cannot be directly extrapolated to human clinical outcomes.

5.2 Antioxidant Activity

Phytochemical analysis of the extract of R. maritimus indicates the presence of reducing sugar, glycoside, gum, tannin and alkaloid-type compounds, and the pharmacological attention of these compounds has prompted investigation of antioxidant activity in a dose-dependent manner. The antioxidant activity of R. maritimus root extracts, specifically, is reported to be stronger than that of aerial parts, in part due to its more concentrated anthraquinone content. The root of the plant represented stronger antioxidant activity and antidiarrhoeal activity in an animal model.

Evidence strength: Evidence is limited to in vitro and animal model studies. No human data for antioxidant endpoints specific to R. maritimus have been published in peer-reviewed literature to date.

5.3 Antimicrobial Activity

The alcoholic extract of R. maritimus has shown antibacterial activity against tested microorganisms, including both Gram-positive and Gram-negative bacteria. Within the broader genus, antimicrobial studies against multiple species of Rumex (including R. crispus, R. confertus, and R. hydrolapathum) have documented inhibitory concentrations in the 62.5–500 μg/mL range for staphylococci, Escherichia coli, Proteus mirabilis, and Pseudomonas aeruginosa using agar and broth dilution methods. Determination of minimal inhibitory concentration revealed that extracts from R. confertus, R. crispus, R. hydrolapathum and R. obtusifolius exerted differential inhibitory effects on the growth of Gram-positive bacteria — staphylococci (MIC = 62.5–125 μg/mL) and Gram-negative bacteria — Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa (MIC = 125–>500 μg/mL); the same extracts inhibited the growth of fungi — Candida spp. or Trichophyton mentagrophytes ATCC 9533 (MIC = 250–500 μg/mL) by agar dilution method.

Evidence strength: In vitro evidence only for the genus; direct clinical antimicrobial data for R. maritimus are absent.

5.4 Anti-inflammatory Activity

The species has been traditionally used by the Meitei community of Manipur for inflammatory conditions. Phytochemical constituents shared with well-studied congeners (emodin, chrysophanol, flavonoids) have demonstrated anti-inflammatory activity in multiple preclinical models across the genus. Some Rumex species have emerged as a good source of traditional medicine for treatment of inflammation and different bacterial infections, with further promising investigations needed on isolated compounds including quercetin 3-O-glucoside, emodin, nepodin, torachrysone, and trans-resveratrol.

Evidence strength: Preclinical and traditional use evidence only; no clinical trial data for anti-inflammatory outcomes specific to R. maritimus have been identified.

5.5 Anticancer / Antiproliferative Activity

The compound 2-methoxystypandrone, isolated from R. maritimus and related dock species, has received preliminary investigation for antiproliferative potential. When isolated from R. japonicus, 2-methoxystypandrone displayed antiproliferative activity against Jurkat cells; this effect was associated with a reduction in mitochondrial membrane potential and an increase in mitochondrial reactive oxygen species. Compounds from the Rumex genus, along with crude extracts, exhibit a broad spectrum of pharmacological activities, including neuroprotective, antimicrobial, anticancer, anti-inflammatory, antioxidant, hepatoprotective, and wound-healing effects.

Evidence strength: In vitro cell-line data only; no animal or human anticancer studies have been published for R. maritimus itself. These findings are exploratory and do not support clinical claims.

5.6 Dermatological Use

The leaves of R. maritimus are used traditionally to cure external burns and ringworm. Its leaves are applied against burns in documented ethnomedicinal practice. No controlled clinical studies evaluating R. maritimus preparations for any dermatological endpoint have been published. Evidence remains at the level of traditional use.

5.7 Laxative Use

R. maritimus and R. nepalensis have long-term medicinal applications in India as substitutes for Rheum palmatum, used to regulate the whole digestive system. The laxative action is attributed to anthraquinone glycosides in the root. The roots of many Rumex species have been used in medicine from ancient times because of their gentle laxative effect. No clinical trials have evaluated the laxative efficacy of R. maritimus specifically. Evidence is based on traditional use and pharmacological inference from the genus's known anthraquinone content.

6. Body Systems and Health Areas of Association

Based on the compiled ethnobotanical and pharmacological literature, R. maritimus has been associated with the following body systems and health areas:

Gastrointestinal system: Laxative, antidiarrheal, antispasmodic, digestive tonic; documented use as a substitute for Rheum (rhubarb) species in India for bowel regulation.
Integumentary (skin) system: Topical use of leaves for burns and ringworm; roots for skin diseases. The roots of Rumex maritimus are used to cure skin diseases.
Musculoskeletal system: Seeds are used to eliminate pain from the back and the lumbar region.
Reproductive system: The seeds are used as sex stimulants and aphrodisiacs in traditional ethnomedicine.
Immune and anti-infective system: Antimicrobial activity documented against Gram-positive and Gram-negative bacteria in preclinical studies.
Hepatic system: Phytochemical investigations reveal constituents that support hepatoprotective activities.
General antioxidant status: Free-radical scavenging activity identified in preclinical assays.

7. Dosage Forms and Doses Reported in Research

Specific clinical dosing data for Rumex maritimus are absent from the peer-reviewed literature, as no human clinical trials have been conducted. The following dosage parameters are drawn exclusively from reported animal studies:

Antidiarrheal study (Rouf et al., 2003, J. Ethnopharmacol.): The extract of R. maritimus produced good diarrheal inhibition in castor oil-induced diarrhea in mice at 250 mg/kg and 500 mg/kg body weight, which was comparable to the standard drug Loperamide at the dose of 3 mg/kg of body weight. These are animal doses and cannot be directly applied to human use.

The broader genus Rumex is harvested and prepared in multiple forms in traditional practice. Crude extracts of Rumex spp. and the pure isolates display various bioactivities, such as antibacterial, anti-inflammatory, antitumor, antioxidant, cardiovascular protection and antiaging activities in preclinical settings, but validated human dose ranges for R. maritimus specifically have not been established.

8. Safety Considerations and Known Interactions

8.1 Oxalic Acid Toxicity

High levels of oxalic acid in Rumex species can cause toxicity, including kidney stones, if consumed in large quantity. Plants can contain quite high levels of oxalic acid, which gives the leaves their acid-lemon flavour. The leaves should not be eaten in large amounts since the oxalic acid can lock up other nutrients in the food, especially calcium, thus causing mineral deficiencies. Oxalic intoxication has at times been reported, mainly in children, due to the high oxalic acid content of the plants.

8.2 Anthraquinone-Associated Adverse Effects

Clinical and toxicological aspects of Rumex species include oxalate accumulation and anthraquinone-associated adverse effects. Major research limitations include the lack of standardized extracts, insufficient clinical evidence, and poor bioavailability of key compounds. The anthraquinone content of dock roots confers a stimulant laxative action which may cause cramping, electrolyte imbalance, or dependency with long-term use. The closely related R. crispus is contraindicated in conditions such as irritable bowel, bowel obstruction, and spastic colon in European herbal practice.

8.3 Toxicological Evidence from Animal Studies

For the related species Rumex dentatus, formal toxicity studies have been conducted under OECD standards. Toxicity studies were done according to OECD standards 425. It belongs to group 5 (LD50 > 2000 mg/kg), which suggests that it is in the lower toxicity class. No equivalent formal acute or subchronic toxicity study has been published specifically for R. maritimus. Toxicological profiles for many Rumex species, especially under chronic administration, remain incomplete, leaving gaps in our understanding.

8.4 Phytotoxic Compounds: Relevance for Safety

Leaf, stem and root extracts of R. maritimus exhibited strong inhibitory effects on root and shoot length of multiple plant species, and 2-methoxystypandrone was purified as the principal phytotoxic substance. 2-Methoxystypandrone reduced the seedling length of Lepidium sativum at concentration ≥ 3 μM; the required 50% growth inhibition concentration for 2-methoxystypandrone ranged 5.8–11.8 μM. The biological significance of this compound for mammalian cell toxicity at doses relevant to human supplement use has not been established.

8.5 Research Gaps and Outstanding Uncertainties

For applying Rumex species to prevent or treat various diseases, additional pharmacological studies are needed to find the mechanisms of action, safety, and efficacy before starting clinical trials. Major research limitations include the lack of standardized extracts, insufficient clinical evidence, and poor bioavailability of key compounds. No human pharmacokinetic data, no drug interaction studies, and no clinical safety data for R. maritimus preparations have been published in peer-reviewed literature. The entire clinical evidence base at this time is absent; all documented effects arise from traditional use, in vitro assays, or animal experiments.

9. Summary of Evidence Strength

The following characterization applies strictly to Rumex maritimus as a dietary supplement ingredient. Evidence strength for individual claims is summarized here for clarity:

Antidiarrheal activity: Preliminary — supported by one animal (mouse) study published in 2003 in Journal of Ethnopharmacology (PMID: 12648830); no human data.
Antioxidant activity: Preliminary — in vitro and animal evidence only, consistent with genus-level data.
Antimicrobial activity: Preliminary — in vitro evidence from whole-plant extract studies; no clinical evidence.
Laxative effect: Plausible from phytochemical inference (anthraquinone content, traditional use); no clinical trial data specific to this species.
Anti-inflammatory activity: Preliminary — genus-level animal/in vitro data; no human studies for R. maritimus.
Anticancer/antiproliferative activity: Early stage — in vitro cell-line only; no animal or human data for R. maritimus.
Dermatological use: Traditional use evidence only; no controlled studies.
Safety: Incomplete; oxalate and anthraquinone toxicity risks are documented at the genus level; no species-specific chronic toxicity data have been published.

References

Health Conditions

Health conditions that Maritime dock may help support.

No conditions available.

Body Systems

Body systems that Maritime dock may help support.

No body systems available.